HU9700425D0 - Use of incubated, citrate-containing leukaemic blood-product for treating tumors - Google Patents

Use of incubated, citrate-containing leukaemic blood-product for treating tumors

Info

Publication number
HU9700425D0
HU9700425D0 HU9700425A HUP9700425A HU9700425D0 HU 9700425 D0 HU9700425 D0 HU 9700425D0 HU 9700425 A HU9700425 A HU 9700425A HU P9700425 A HUP9700425 A HU P9700425A HU 9700425 D0 HU9700425 D0 HU 9700425D0
Authority
HU
Hungary
Prior art keywords
leukaemic
citrate
incubated
blood
product
Prior art date
Application number
HU9700425A
Other languages
Hungarian (hu)
Inventor
Robert Martyn
Original Assignee
Martyn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Martyn filed Critical Martyn
Priority to HU9700425A priority Critical patent/HU9700425D0/en
Publication of HU9700425D0 publication Critical patent/HU9700425D0/en

Links

HU9700425A 1997-02-12 1997-02-12 Use of incubated, citrate-containing leukaemic blood-product for treating tumors HU9700425D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU9700425A HU9700425D0 (en) 1997-02-12 1997-02-12 Use of incubated, citrate-containing leukaemic blood-product for treating tumors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9700425A HU9700425D0 (en) 1997-02-12 1997-02-12 Use of incubated, citrate-containing leukaemic blood-product for treating tumors

Publications (1)

Publication Number Publication Date
HU9700425D0 true HU9700425D0 (en) 1997-03-28

Family

ID=89994743

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9700425A HU9700425D0 (en) 1997-02-12 1997-02-12 Use of incubated, citrate-containing leukaemic blood-product for treating tumors

Country Status (1)

Country Link
HU (1) HU9700425D0 (en)

Similar Documents

Publication Publication Date Title
EP0989857A4 (en) Novel therapeutic agents that modulate enzymatic processes
PL336290A1 (en) Sulphonamides for treating endothelin-involving disorders
ZA983852B (en) Therapy for constipation
EP1077704A4 (en) Combination therapy for treatment of depression
PL348107A1 (en) Therapy for improving cognition
SI1176964T1 (en) Uses of et743 for treating cancer
IL135232A0 (en) 21-hydroxy-6, 19-oxidoprogesterone for treating excess of glucocorticoids
PL344331A1 (en) Combination therapy for treatment of refractory depression
HK1028350A1 (en) Leptin as an inhibitor of tumor cell proliferation.
EP0792168A4 (en) Novel tumor suppressor gene, hic-1
IL148579A0 (en) Oncolytic combinations for the treatment of cancer
ZA9811629B (en) The use of MMP inhibitors for the treatment of ocular angiogenesis.
ZA973622B (en) Use of forms of hyaluronic acid (HA) for the treatment of cancer.
AU7492198A (en) Use of an odorant for treating headaches
GB9700939D0 (en) Therapy
GB9816556D0 (en) Therapy
AU8068198A (en) Methods for treating human cancers
PL338726A1 (en) Improved treatment of hides
GB9725114D0 (en) Treatment of pruritus
HUP0101947A3 (en) Combination for the treatment of tumors
HU9700425D0 (en) Use of incubated, citrate-containing leukaemic blood-product for treating tumors
HUP0100365A3 (en) Combination therapy for the treatment of aids
AU1940800A (en) Combination therapy for the treatment of sepsis
GB9703633D0 (en) Cancer therapy
AU8041798A (en) Agent for treating patients suffering from tumours